Article

Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells

2020-05-07

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Acute myeloid leukemia (AML) is a heterogenic lethal disorder characterized by the accumulation of abnormal myeloid progenitor cells in the bone marrow which results in hematopoietic failure. Despite various efforts in detection and treatment, many patients with AML die of this cancer. That is why it is important to develop novel therapeutic options, employing s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 271d4402-a746-5b56-8d8a-438eebb5bd31
DOI: 10.21203/rs.2.19004/v4

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cellsDOI 10.21203/rs.2.19004/v4Read

Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cellsSemantic proximity Read

PARP10 is highly expressed and associated with inferior outcomes in acute myeloid leukemia.Semantic proximity Read

PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndromeSemantic proximity Read

PARP-1 Overexpression as an Independent Prognostic Factor in Adult Non-M3 Acute Myeloid Leukemia.Semantic proximity Read

PARP-1 improves leukemia outcomes by inducing parthanatos during chemotherapySemantic proximity Read

Prognostic value of circular RNAs expression and correlation with clinicopathological features in acute myeloid leukemia; a comprehensive systematic review and meta-analysisSemantic proximity Read

The Multifactorial Role of PARP-1 in Tumor MicroenvironmentSemantic proximity Read

Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case seriesSemantic proximity Read

High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effectsSemantic proximity Read

Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategiesSemantic proximity Read

Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience.Semantic proximity Read

Effect of MYH10 Variant on Acute Leukemia with Low Platelet Count PrognosisSemantic proximity Read